Orthopedic implants market seen reaching $73.32 billion by 2032
Allied Market Research projects the global orthopedic implants market will grow from $47.19 billion in 2022 to $73.32 billion by 2032, driven by aging populations, more orthopedic disease and faster adoption of new implant technologies. The report points to knee and reconstructive joint replacements as leading segments, while Asia-Pacific is expected to post the fastest growth.
Why it matters: - The orthopedic implants market is tied to rising demand for procedures that restore mobility and treat bone, joint and spine disorders. - Growth in the market could shape spending, product development and investment across hospitals, device makers and suppliers. - The report projects the market will expand at a 4.5% CAGR from 2023 to 2032.
What happened: - Allied Market Research published a report on the global orthopedic implants market covering product type, biomaterial, type and region. - The market was valued at $47.19 billion in 2022 and is projected to reach $73.32 billion by 2032. - The report covers reconstructive joint replacements, spinal implants, dental implants, trauma, orthobiologics and other categories. - The study also looks at metallic, ceramic, polymeric and other biomaterials, plus knee, hip, wrist and shoulder, dental, spine, ankle and other implant types. - The report includes analysis of investment pockets, strategies, drivers, opportunities, market sizing, competition and trends. - A sample copy of the report is available.
The details: - Aging populations are increasing cases of osteoporosis and arthritis, which is lifting demand for joint replacements. - Technology shifts such as 3D-printed implants, biodegradable materials and smart implants are improving treatment outcomes. - More sports injuries and road accidents are adding to implant demand. - Demand for minimally invasive surgery is supporting adoption. - Higher healthcare spending, especially in developing nations, is also supporting growth. - The report flags 3D printing, smart implants, biodegradable and bioactive implants, and robotics in orthopedic surgery as future trends. - The reconstructive joint replacements segment held more than one-third of global revenue in 2022 and is expected to lead by 2032. - The ortho-biologics segment is projected to post the fastest CAGR at 6.0% from 2023 to 2032. - Metallic biomaterials held nearly two-thirds of global revenue in 2022. - The
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Small Business News Today
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.